Central Trust Company’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-98
Closed -$2.8K 1411
2025
Q2
$2.8K Hold
98
﹤0.01% 1283
2025
Q1
$3.24K Hold
98
﹤0.01% 1267
2024
Q4
$2.82K Hold
98
﹤0.01% 1274
2024
Q3
$2.74K Hold
98
﹤0.01% 1225
2024
Q2
$2.36K Hold
98
﹤0.01% 1266
2024
Q1
$2.65K Hold
98
﹤0.01% 1247
2023
Q4
$2.72K Hold
98
﹤0.01% 1247
2023
Q3
$2.75K Buy
+98
New +$2.87K ﹤0.01% 1228
2022
Q3
Sell
-13
Closed 1294
2022
Q2
$0 Hold
13
﹤0.01% 1355
2022
Q1
$0 Buy
+13
New +$322 ﹤0.01% 1334

Other funds holding ALKS

Central Trust Company's ALKS Position: Q3 2025 in Review

Central Trust Company sold out of Alkermes (ALKS) in Q3 2025, closing a stake of 98 shares — an estimated $2.8K sold.

Central Trust Company first reported a position in ALKS in Q1 2022 and held it in 10 quarters. The position peaked at $3.24K in Q1 2025. 358 funds tracked by Wall St. Rank hold ALKS as of Q3 2025.

  • Central Trust Company reported no remaining Alkermes position as of Q3 2025 after selling out during the quarter.
  • Central Trust Company sold 98 Alkermes shares in Q3 2025, an estimated $2.8K.
  • Central Trust Company first reported a position in Alkermes in Q1 2022 and held it in 10 quarters.
  • Central Trust Company's Alkermes position peaked at $3.24K in Q1 2025.
  • 358 funds tracked by Wall St. Rank held Alkermes as of Q3 2025.

Based on Central Trust Company's 13F filing for Q3 2025, filed 6 Nov 2025.